We are pleased to announce the establishment of Sanodyne Therapeutics, Inc., a biotechnology company dedicated to bringing innovative therapies to patients suffering from peripheral neuropathy and neuropathic pain.

Leveraging cutting-edge science and deep expertise, we are committed to developing novel treatments that go beyond symptom control and address the underlying causes of disease.

Our mission is to deliver true relief and healing to patients worldwide, and we will continue to advance our research and development efforts with this goal at the forefront.